Infectious Diseases Archive — Page 2 of 13

Colorized scanning electron micrograph showing numerous rod-shaped Escherichia coli bacteria clustered together against a dark background.
April 18, 2026

Rapid bloodstream infection testing shows high potential for timely, lifesaving treatment: Study

Gram-negative bacteria bloodstream infections are a major cause of illness and death worldwide, especially where antimicrobial resistance is more common.  

April 3, 2026

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems,” said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

Jennifer Gaddy, PhD
February 24, 2026

Jennifer Gaddy elected to American Academy of Microbiology 

Gaddy is a leading researcher in bacterial pathogenesis, innate immunity and reproductive immunology.

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
February 18, 2026

Vanderbilt research offers new hope for preventing repeated C. diff infections

Treatment options are limited for the more than 500,000 people in the U.S. who are diagnosed annually with C. diff infections, but researchers are working on potential vaccines, therapeutic antibodies and — most recently — nanobodies, to prevent and treat C. diff infections.

Two researchers stand beside shelves of laboratory bottles, pipettes, containers, and other equipment in a research lab.
February 18, 2026

Novel vaccine protects against C. diff disease and recurrence

New study represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.

(iStock)
February 13, 2026

Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.